老年糖尿病患者肌少症管理的研究进展

Research progress in the management of sarcopenia in elderly diabetic patients

老年糖尿病患者因代谢功能变化、营养失调等原因加快了肌力减退及肌肉质量下降的速度,增加了肌少症的发病率。同时,肌少症不仅增加了老年患者跌倒、骨折等不良结局的发生风险,还可促进糖尿病的发生发展,甚至危害患者的生命健康。目前,老年糖尿病患者合并肌少症的治疗仍处于探索阶段,早期筛查、识别危险因素、积极干预是预防或延缓肌少症的有效策略。本文重点对老年糖尿病患者合并肌少症的筛查、评估方法、危险因素及非药物干预策略进行梳理及总结,以期为我国临床工作者制定老年糖尿病患者合并肌少症相关干预策略及管理流程提供参考。

Older diabetic patients have an increased incidence of sarcopenia due to changes in metabolic function and nutritional imbalances that accelerate the rate of muscle weakness and loss of muscle mass in patients.At the same time,sarcopenia not only increases the risk of adverse outcomes such as falls and fractures in elderly patients,it can also promote the development of diabetes and even put the lives of elderly patients at risk.At present,the treatment of concomitant sarcopenia in elderly diabetic patients is still in the exploratory stage.Early screening,identification of risk factors,and active intervention are effective strategies for preventing or delaying sarcopenia.This article focuses on the screening,assessment methods,risk factors and non-pharmacological intervention strategies for sarcopenia in elderly diabetic patients,with a view to providing reference for clinical practitioners in China to develop intervention strategies and management processes related to sarcopenia in elderly diabetic patients.